ANZCA has endorsed a selection of guidelines developed by other organisations.
Anaphylaxis Management Guidelines
The Australian and New Zealand Anaesthetic Allergy Group (ANZAAG), in conjunction with ANZCA, through the Anaesthetic Allergy Subcommittee of the Quality and Safety Committee, has developed anaphylaxis management guidelines. The documents are designed to be used as a crisis management package in the event of an acute perioperative anaphylaxis.
ANZAAG has a policy of continuous resource monitoring and quality improvement. Feedback from ANZCA Fellows is welcome. Changes to resources will occur in accordance with current best evidence. Please check the ANZAAG website to ensure your department is using the most up-to-date version of resources. The relevant website is not maintained by ANZCA.
If you printed out the ANZAAG Anaphylaxis Management Guidelines prior to May 28, 2013 please replace the refractory management card with the June 2013 revision now available. The initial dose of IV Salbutamol in a paediatric patient should read 5 mcg/kg/min rather than 5 mcg/min.
Malignant Hyperthermia Crisis Management
Malignant Hyperthermia Australia and New Zealand, a group of anaesthetists and scientists with a special interest in malignant hyperthermia, have developed a resource kit. The comprehensive kit includes guidelines on resuscitation, lines and investigations, dantrolene reconstitution, cooling, logistics and other topics. Please note the relevant website is not maintained by ANZCA.
The Association of Anaesthetists of Great Britain and Ireland has released a safety guideline regarding the management of severe local anaesthetic toxicity. The guideline was produced by a working party that comprised Grant Cave, Will Harrop-Griffiths (chair), Martyn Harvey, Tim Meek, John Picard, Tim Short and Guy Weinberg. Accompanying notes are also available. Please note the relevant website is not maintained by ANZCA.
In August 2010, the Australian Commission on Safety and Quality in Health Care released a publication entitled National Recommendations for User-applied Labelling of Injectable Medicines, Fluids and Lines. This publication and related resources are available here. Please note the relevant website is not maintained by ANZCA.
OSSIE Guide to Clinical Handover Improvement
The OSSIE Guide to Clinical Handover Improvement, developed by the Australian Commission on Safety and Quality in Health Care, assists with the implementation of a standardised process for handover that suits local context. It is complemented by the Implementation Toolkit for Clinical Handover Improvement, a "how to guide" for managers and clinicians reviewing local clinical handover processes. Please note the relevant website is not maintained by ANZCA.
Patient Blood Management Guidelines
The National Blood Authority is developing a series of six evidence-based patient blood management guidelines. To date, ANZCA has endorsed the first three modules, as follows:
Associate Professor Larry McNicol is a member of the Expert Working Group and chaired the Clinical/Consumer Reference Group for modules 1 and 2. Please note the relevant website is not maintained by ANZCA.
In August 2009, ANZCA welcomed the introduction of the surgical safety checklist, an important clinical tool for Australian and New Zealand hospitals. Professor Alan Merry was the principal investigator for Auckland, one of the eight pilot sites in the World Health Organization global study. ANZCA also assisted in refining the checklist, which emphasises teamwork and communication, for use in Australia and New Zealand. The checklist is not intended to be comprehensive; additions and modifications are encouraged to fit local practice and responsibilities.